Research ReportZTS
Zoetis (ZTS): Growth Reset, Still a Premium Franchise
Zoetis remains a high-quality animal health leader, but 2026 guidance cuts and softer U.S. companion-animal demand temper the near-term setup. The stock looks like a disciplined Buy with a fair value of $132.
May 7, 202623 MIN